Download PDF
Int J Angiol
DOI: 10.1055/a-2640-0775
Original Article

Investigation of the Survival Time of Patients Who Underwent Endovascular Treatment Due to Type 3 Aortic Dissection and Factors Affecting This Duration

Mehmet Işık 
1   Department of Cardiovascular Surgery, Necmettin Erbakan University Faculty of Medicine, Konya, Türkiye
,
Yalçın Günerhan 
1   Department of Cardiovascular Surgery, Necmettin Erbakan University Faculty of Medicine, Konya, Türkiye
,
Ömer Tanyeli 
1   Department of Cardiovascular Surgery, Necmettin Erbakan University Faculty of Medicine, Konya, Türkiye
,
Serkan Yıldırım 
1   Department of Cardiovascular Surgery, Necmettin Erbakan University Faculty of Medicine, Konya, Türkiye
,
Ali Demiray 
1   Department of Cardiovascular Surgery, Necmettin Erbakan University Faculty of Medicine, Konya, Türkiye
› Author Affiliations
Funding None.
› Further Information
   Permissions and Reprints

Abstract

Objective

This study aimed to analyze the survival time of patients who underwent thoracic endovascular aortic replacement (TEVAR) due to acute type 3 aortic dissection and to investigate comorbid conditions and dissection characteristics that affect survival time.

Materials and Methods

Between 2013 and 2023, 94 patients who underwent TEVAR for type 3 dissection were retrospectively investigated. Survival time and factors affecting this time (comorbidity and dissection characteristics) were analyzed.

Results

The most common comorbidities were hypertension (88%). There was no significant difference between the demographic data of surviving and deceased patients. During the follow-up period, 57% of the patients survived, and 43% of the patients died. The mean survival time after TEVAR was 20.1 (0–108) months among patients who died and 47.7 (2–120) months for patients who lived. The mean number of comorbidities was 2.13 in patients who died and 2.25 in patients who survived. Survival distribution according to the type of interventional procedure was 50% for partial closure of the subclavian artery, 38.1% for complete closure, and 66.2% for closure starting from the distal subclavian artery (p = 0.06). Survival rate was significantly higher in patients who underwent reintervention (p = 0.005). Mortality was 9.5% in the early period, 25.5% in the first year, 29.7% in the second year, 34% in the third year, and 39.3% in the first 5 years.

Conclusion

In our study, the survival rate was higher in patients who were followed regularly, and reintervention was applied when necessary. Therefore, we believe that undetected or untreated complications after TEVAR, rather than comorbid conditions, negatively affect survival more.

Keywords

TEVAR - PETTICOAT - type 3 dissection - De Bakey type 3 dissection - Stanford type B dissection

Ethical Approval

Permission was granted by the local ethics committee for the study protocol (2024/4791) and every patient provided written informed consent.


Authors' Contributions

M.I. contributed to study planning, manuscript writing, data collection, and overall supervision. Y.G. contributed to study planning, data collection, and supervision. Ö.T. and S.Y. were involved in study planning and supervision. A.D. contributed to study planning, data collection, and supervision.




Publication History

Article published online:
02 July 2025

© 2025. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Nienaber CA, Clough RE. Management of acute aortic dissection. Lancet 2015; 385 (9970): 800-811
    Search in Google Scholar
  • 2 Acosta S, Blomstrand D, Gottsäter A. Epidemiology and long-term prognostic factors in acute type B aortic dissection. Ann Vasc Surg 2007; 21 (04) 415-422
    Search in Google Scholar
  • 3 Le Huu A, Preventza O. Endovascular repair of acute type B thoracic aortic dissection. Ann Cardiothorac Surg 2021; 10 (06) 793-800
    Search in Google Scholar
  • 4 Brunkwall J, Kasprzak P, Verhoeven E. et al.; ADSORB Trialists. Endovascular repair of acute uncomplicated aortic type B dissection promotes aortic remodelling: 1 year results of the ADSORB trial. Eur J Vasc Endovasc Surg 2014; 48 (03) 285-291
    Search in Google Scholar
  • 5 Kamman AV, Brunkwall J, Verhoeven EL, Heijmen RH, Trimarchi S. ADSORB trialists. Predictors of aortic growth in uncomplicated type B aortic dissection from the Acute Dissection Stent Grafting or Best Medical Treatment (ADSORB) database. J Vasc Surg 2017; 65 (04) 964-971.e3
    Search in Google Scholar
  • 6 Patel JJ, Kasprzak P, Pfister K. et al. Early outcomes associated with use of the Zenith TX2 Dissection Endovascular Graft for the treatment of Stanford type B aortic dissection. J Vasc Surg 2021; 74 (02) 547-555
    Search in Google Scholar
  • 7 Tang DG, Dake MD. TEVAR for acute uncomplicated aortic dissection: immediate repair versus medical therapy. Semin Vasc Surg 2009; 22 (03) 145-151
    Search in Google Scholar
  • 8 Harky A, Hussain SMA, MacCarthy-Ofosu B, Ahmad MU. The role of thoracic endovascular aortic repair (TEVAR) of thoracic aortic diseases in patients with connective tissue disorders - A literature review. Braz J Cardiovasc Surg 2020; 35 (06) 977-985
    Search in Google Scholar
  • 9 Nienaber CA, Kische S, Zeller T. et al. Provisional extension to induce complete attachment after stent-graft placement in type B aortic dissection: the PETTICOAT concept. J Endovasc Ther 2006; 13 (06) 738-746
    Search in Google Scholar
  • 10 Estrera AL, Miller III CC, Safi HJ. et al. Outcomes of medical management of acute type B aortic dissection. Circulation 2006; 114 (1 Suppl): I384-I389
    Search in Google Scholar
  • 11 Tsai TT, Fattori R, Trimarchi S. et al.; International Registry of Acute Aortic Dissection. Long-term survival in patients presenting with type B acute aortic dissection: insights from the International Registry of Acute Aortic Dissection. Circulation 2006; 114 (21) 2226-2231
    Search in Google Scholar
  • 12 Chung J, Corriere MA, Veeraswamy RK. et al. Risk factors for late mortality after endovascular repair of the thoracic aorta. J Vasc Surg 2010; 52 (03) 549-554 , discussion 555
    Search in Google Scholar
  • 13 Burke CR, Bavaria JE. The role of thoracic endovascular repair in chronic type B aortic dissection. Semin Thorac Cardiovasc Surg 2020; 32 (01) 21-24
    Search in Google Scholar
  • 14 Fattori R, Tsai TT, Myrmel T. et al. Complicated acute type B dissection: is surgery still the best option?: a report from the International Registry of Acute Aortic Dissection. JACC Cardiovasc Interv 2008; 1 (04) 395-402
    Search in Google Scholar
  • 15 Clouse WD, Hallett Jr JW, Schaff HV. et al. Acute aortic dissection: population-based incidence compared with degenerative aortic aneurysm rupture. Mayo Clin Proc 2004; 79 (02) 176-180
    Search in Google Scholar
  • 16 Lombardi JV, Cambria RP, Nienaber CA. et al.; STABLE investigators. Prospective multicenter clinical trial (STABLE) on the endovascular treatment of complicated type B aortic dissection using a composite device design. J Vasc Surg 2012; 55 (03) 629-640.e2
    Search in Google Scholar
  • 17 Chen Y, Zhang S, Liu L, Lu Q, Zhang T, Jing Z. Retrograde type A aortic dissection after thoracic endovascular aortic repair: a systematic review and meta-analysis. J Am Heart Assoc 2017; 6 (09) e004649
    Search in Google Scholar
  • 18 Stavropoulos SW, Charagundla SR. Imaging techniques for detection and management of endoleaks after endovascular aortic aneurysm repair. Radiology 2007; 243 (03) 641-655
    Search in Google Scholar
  • 19 Tolia AJ, Landis R, Lamparello P, Rosen R, Macari M. Type II endoleaks after endovascular repair of abdominal aortic aneurysms: natural history. Radiology 2005; 235 (02) 683-686
    Search in Google Scholar
  • 20 Gunerhan Y, Isik M, Dereli Y. et al. Assessing volumetric changes in abdominal aortic aneurysms following endovascular repair. Cardiovasc J S Afr 2021; 32 (04) 182-187
    Search in Google Scholar
  • 21 Çil BE, Canyiğit M, Ciftçi TT. et al. [Endovascular treatment of aortic lesions using the Medtronic Talent system: single center experience with mid-term follow-up]. Anadolu Kardiyol Derg 2008; 8 (02) 134-138
    Search in Google Scholar
  • 22 Nienaber CA, Kische S, Rousseau H. et al.; INSTEAD-XL trial. Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial. Circ Cardiovasc Interv 2013; 6 (04) 407-416
    Search in Google Scholar
  • 23 Nienaber CA, Powell JT. Management of acute aortic syndromes. Eur Heart J 2012; 33 (01) 26-35b
    Search in Google Scholar
  • 24 Xie E, Yang F, Liu Y. et al. Timing and outcome of endovascular repair for uncomplicated type B aortic dissection. Eur J Vasc Endovasc Surg 2021; 61 (05) 788-797
    Search in Google Scholar
  • 25 Potter HA, Ding L, Han SM, Fleischman F, Weaver FA, Magee GA. Spinal cord ischemia and reinterventions following thoracic endovascular repair for acute type B aortic dissections. J Vasc Surg 2024; 80 (03) 656-664
    Search in Google Scholar